Spondyloarthritis is a family of inflammatory diseases that primarily attack the spine and joints where ligaments and tendons attach to bone. Unlike osteoarthritis, which results from wear and tear, spondyloarthritis is driven by an overactive immune system. It tends to strike younger adults, typically before age 40, and causes a distinctive pattern of back pain that gets better with movement and worse with rest.
The term is an umbrella that covers several related conditions. Understanding which type you’re dealing with, and how it differs from ordinary back pain, is key to getting the right treatment early enough to prevent lasting damage.
Types of Spondyloarthritis
Spondyloarthritis splits into two main categories based on where inflammation concentrates. Axial spondyloarthritis targets the spine and sacroiliac joints (the joints connecting your lower spine to your pelvis). Peripheral spondyloarthritis primarily affects the arms and legs, including the knees, ankles, and feet.
Axial spondyloarthritis itself breaks down further. When damage to the sacroiliac joints is visible on standard X-rays, the condition is called ankylosing spondylitis. When the same pattern of symptoms and inflammation exists but X-rays still look normal, it’s classified as non-radiographic axial spondyloarthritis. MRI can often detect inflammation at this earlier stage. Some people with the non-radiographic form eventually progress to ankylosing spondylitis, but many never do.
Several specific diseases fall under the spondyloarthritis umbrella, including psoriatic arthritis, reactive arthritis, and arthritis linked to inflammatory bowel disease. These conditions share overlapping genetics, similar immune pathways, and a common tendency to inflame the spots where tendons and ligaments anchor into bone.
What Causes It
The hallmark process in spondyloarthritis is enthesitis, which is inflammation at the points where tendons and ligaments meet bone. These connection points, called entheses, are scattered throughout the body but are especially concentrated around the spine, pelvis, and heel. Mechanical stress at these sites activates immune pathways that trigger inflammation and, over time, abnormal new bone growth. This link between physical stress and immune overreaction is what makes spondyloarthritis distinct from other forms of arthritis.
Genetics play a major role. A gene called HLA-B27 is present in roughly 75% of people with spondyloarthritis, compared to only about 7% of the general population. Carrying this gene increases the risk of developing the disease roughly 39-fold. That said, most people who are HLA-B27 positive never develop spondyloarthritis, which means other genetic and environmental factors are also at play.
How Inflammatory Back Pain Feels Different
The back pain of spondyloarthritis follows a pattern that’s nearly opposite to the mechanical back pain most people experience from lifting something heavy or sitting too long. Recognizing this pattern is critical because it’s often the first clue that something autoimmune is happening.
Inflammatory back pain typically has these features:
- Onset before age 40 and a gradual, creeping start rather than a sudden injury
- Morning stiffness lasting 30 minutes or more that loosens up as you move
- Improvement with exercise and worsening with rest or inactivity
- Night pain that may wake you in the second half of the night, improving once you get up
- Duration of at least 3 months of persistent or recurring symptoms
- Alternating buttock pain, shifting from one side to the other
If you have back pain lasting three months or more with at least four of these features, the pattern is consistent with inflammatory back pain. Mechanical back pain, by contrast, tends to worsen with activity, improve with rest, and often has a clear triggering event.
Symptoms Beyond the Spine
Spondyloarthritis is a systemic disease, meaning it can cause problems well beyond joints. The most common non-joint symptom is uveitis, a painful inflammation of the eye that causes redness, light sensitivity, and blurred vision. Uveitis can affect up to 25% of people with certain forms of spondyloarthritis and needs prompt treatment to prevent vision damage.
Skin involvement is also common, particularly psoriasis, which causes raised, scaly patches. Inflammatory bowel disease, including Crohn’s disease and ulcerative colitis, overlaps significantly with spondyloarthritis. These conditions share immune pathways, and having one raises the likelihood of developing another. Some people notice gut symptoms years before joint problems appear, or vice versa.
Enthesitis outside the spine frequently affects the Achilles tendon and the bottom of the heel, causing pain that’s easily mistaken for plantar fasciitis. Swelling of an entire finger or toe, sometimes called “sausage digit,” is another telltale sign, especially in psoriatic arthritis.
How It’s Diagnosed
There is no single blood test that confirms spondyloarthritis. Diagnosis relies on a combination of symptoms, physical examination, blood work, and imaging. Blood tests typically check for HLA-B27 and markers of inflammation like C-reactive protein, though normal levels don’t rule the condition out.
MRI of the sacroiliac joints is the most sensitive imaging tool for early disease. It can detect bone marrow edema, a sign of active inflammation within the bone, before any structural damage shows up on X-ray. Radiologists look for areas of high signal intensity in specific quadrants of the sacroiliac joint, assessing both the extent and depth of the inflammation. X-rays remain useful for identifying more advanced changes, including the joint erosion and fusion seen in established ankylosing spondylitis.
One of the biggest challenges is diagnostic delay. Because back pain is so common and the disease often starts in young adults, spondyloarthritis is frequently dismissed as muscular pain or attributed to stress. The average delay between symptom onset and diagnosis has historically been seven or more years, though awareness has improved.
Treatment Approach
Anti-inflammatory medications are the first line of treatment. These drugs reduce both pain and the underlying inflammation driving the disease. Not everyone responds to the same one. Research using individualized trials found that no single anti-inflammatory was preferred by more than 39% of patients, which means finding the right fit often requires trying more than one option.
Regular exercise is equally important and is considered a core part of treatment, not just a supplement to medication. Stretching, strengthening, and cardiovascular exercise help maintain spinal mobility, reduce stiffness, and can slow the loss of flexibility over time. Physical therapy programs tailored to spondyloarthritis focus on posture, chest expansion, and spinal range of motion.
When anti-inflammatory drugs aren’t enough, the next step is biologic therapy or targeted synthetic medications. These drugs block specific immune signals that drive inflammation. They can dramatically reduce symptoms and, in some cases, slow structural damage. The decision to start biologics is based on how active the disease remains despite first-line treatment, how much it affects daily function, and whether imaging shows ongoing inflammation.
How the Disease Progresses
The long-term concern with axial spondyloarthritis is new bone formation along the spine. The body responds to chronic inflammation by laying down extra bone at the edges of vertebrae, forming bony bridges called syndesmophytes. Over years or decades, these bridges can fuse vertebrae together, reducing spinal flexibility and, in severe cases, locking the spine in a fixed position.
Not everyone progresses to spinal fusion. The strongest predictors of new bone growth are male sex, persistently elevated inflammation markers in the blood, and already having at least one syndesmophyte. Vertebral corners that show both active inflammation and fatty changes on MRI carry the highest risk of developing new bony bridges, with roughly a fourfold increase compared to vertebral corners that look normal.
Smoking accelerates progression and reduces the effectiveness of treatment. Maintaining low levels of inflammation through consistent treatment and staying physically active are the most effective strategies for slowing structural damage. Early diagnosis and treatment give the best chance of preserving long-term spinal mobility.